Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression
Jennifer L. Vande Voort, Scott S. Orth, Julia Shekunov, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2021) Vol. 61, Iss. 1, pp. 46-55
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Pharmacogenomics in treatment of depression and psychosis: an update
Marin M. Jukić, F. Milosavljević, Espen Molden, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 12, pp. 1055-1069
Open Access | Times Cited: 42
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials
F. Milosavljević, Prof. Espen Molden, Magnus Ingelman‐Sundberg, et al.
European Neuropsychopharmacology (2024) Vol. 81, pp. 43-52
Open Access | Times Cited: 10
Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis
Mary Bunka, Gavin Wong, Daniel Kim, et al.
Psychiatry Research (2023) Vol. 321, pp. 115102-115102
Open Access | Times Cited: 19
Pharmacogenomic Clinical Support Tools for the Treatment of Depression
Matthew L. Baum, Alik S. Widge, Linda L. Carpenter, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 7, pp. 591-607
Closed Access | Times Cited: 7
Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial
Lei Xu, Liyin Li, Qiutang Wang, et al.
Journal of Affective Disorders (2024) Vol. 359, pp. 117-124
Open Access | Times Cited: 4
Pharmacogenetics: Opportunities for the All of Us Research Program and Other Large Data Sets to Advance the Field
Philip E. Empey, Jason H. Karnes, Julie A. Johnson
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 111-130
Closed Access
Evaluating The Effectiveness of Pharmacogenomics-Based Care in Depression Compared to Standard Care: A Review of Current Evidence
Chinonyelum Emmanuel Agbo, Ikponmwosa Jude Ogieuhi, Chidera Stanley Anthony, et al.
Current Treatment Options in Psychiatry (2025) Vol. 12, Iss. 1
Closed Access
Psychiatric Genetics in Clinical Practice: Essential Knowledge for Mental Health Professionals
Aaron D. Besterman, M.A. Alnor, Oscar M. Ramirez, et al.
American Journal of Psychiatry (2025)
Closed Access
Exploring perceived barriers and attitudes in young adults towards antidepressant pharmacotherapy, including the implementation of pharmacogenetic testing to optimize prescription practices
Bradley Roberts, Zahra Cooper, Georgia Landery, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Child and adolescent psychiatrists’ use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice
Takahiro Soda, Amanda R. Merner, Brent J. Small, et al.
Psychiatry Research (2023) Vol. 325, pp. 115246-115246
Closed Access | Times Cited: 10
High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing
Sara Nooraeen, Paul E. Croarkin, Jennifer R. Geske, et al.
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 1, pp. 28-33
Closed Access | Times Cited: 3
Drug metabolizing enzymes pharmacogenetic variation-informed antidepressant therapy approach for common mental disorders: A systematic review and meta-analysis
Santenna Chenchula, Atal Shubham, Jhaj Ratinder, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 832-844
Closed Access | Times Cited: 3
Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application
Lara Murphy, Trehani M. Fonseka, Chad A. Bousman, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 593-605
Closed Access | Times Cited: 22
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic
Abdullah Al Maruf, Chad A. Bousman
Psychiatry and Clinical Neurosciences Reports (2022) Vol. 1, Iss. 2
Closed Access | Times Cited: 13
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
Bradley Roberts, Zahra Cooper, Stephanie Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward
Mark A. Frye, Charles B. Nemeroff
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 282-284
Open Access | Times Cited: 6
Pharmacogenomics to support mental health medication therapy management: Clinical practice considerations and a conceptual framework to enhance patient care
Jeffrey R. Bishop, Mark E. Schneiderhan, Tiana Butler, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2023) Vol. 7, Iss. 2, pp. 160-170
Open Access | Times Cited: 6
The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?
Lisa B. Namerow, Jeffrey R. Strawn
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 1, pp. 1-3
Closed Access | Times Cited: 1
Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study
Duncan C. Honeycutt, Thomas J. Blom, Laura B. Ramsey, et al.
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 1, pp. 42-51
Closed Access | Times Cited: 1
Review: Child Psychiatry in the Era of Genomics: The Promise of Translational Genetics Research for the Clinic
Sarah E. Fitzpatrick, Irene Antony, Erika L. Nurmi, et al.
JAACAP Open (2024)
Open Access | Times Cited: 1
Genomics-informed neuropsychiatric care for neurodevelopmental disorders: Results from a multidisciplinary clinic
Aaron D. Besterman, David J. Adams, Nicole R. Wong, et al.
Genetics in Medicine (2024), pp. 101333-101333
Open Access | Times Cited: 1
Pediatric Psychopharmacology for Depressive and Anxiety Disorders
Jeffrey R. Strawn, Samuel Vaughn, Laura B. Ramsey
FOCUS The Journal of Lifelong Learning in Psychiatry (2022) Vol. 20, Iss. 2, pp. 184-190
Open Access | Times Cited: 6
Contrasting ABCB1 pharmacogenetics and psychotropic responses in child and adolescent psychiatry: a case comparison
Pragya Kalla, Lisa B. Namerow, Sophia Walker, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 3, pp. 131-139
Closed Access | Times Cited: 3
PISTACHIo (PreemptIon of diSrupTive behAvior in CHIldren): real-time monitoring of sleep and behavior of children 3–7 years old receiving parent–child interaction therapy augment with artificial intelligence — the study protocol, pilot study
Maria Saliba, Noelle Drapeau, Michelle Skime, et al.
Pilot and Feasibility Studies (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Editorial: Beyond Red Light, Green Light: Examining the Role of Pharmacogenomics in Evidence-Based Care in Child and Adolescent Psychiatry
Lisa B. Namerow, Laura B. Ramsey, Salma Malik, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2021) Vol. 61, Iss. 1, pp. 29-31
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top